VAERS Explorer
Back to explore

Report #2870592

Received Nov 4, 2025

ER / ED visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Oct 13, 2025
Onset
Oct 15, 2025
Days to onset
2
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (4)

ErythemaFatigueHeadachePeripheral swelling

Symptom narrative

Upper arm swelling; redness; Fatigue; headache; This non-serious case was reported by a consumer and described the occurrence of swelling arm in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included amoxicillin. On 13-OCT-2025, the patient received the 1st dose of Shingrix. On 15-OCT-2025, 2 days after receiving Shingrix, the patient experienced swelling arm (Verbatim: Upper arm swelling), erythema (Verbatim: redness), fatigue (Verbatim: Fatigue) and headache (Verbatim: headache). The outcome of the swelling arm, erythema, fatigue and headache were not resolved. It was unknown if the reporter considered the swelling arm, erythema, fatigue and headache to be related to Shingrix. It was unknown if the company considered the swelling arm, erythema, fatigue and headache to be related to Shingrix. Additional Information: GSK Receipt Date: 19-OCT-2025 Patient also received Steroids for cellulitis. The batch number was not provided, and we are unable to contact the reporter.

Other medications

AMOXICILLIN